Ignite Creation Date:
2024-10-25 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06542731
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-08-01
Brief Title:
An Open-label Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Docetaxel and Ramucirumab as Second-line Therapy in Patients With Advanced or Recurrent Non-small Cell Lung Cancer
Sponsor:
None
Organization:
None
Conditions & Keywords Data
Conditions:
Keywords: